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To the Editor,
We read with interest the report by Marusic
et al.1 who expanded on the histopathological
features of melanocytic neoplasms in a family
with an inherited BAP1 mutation.
Marusic et al.1 described the presence of
nuclear pseudoinclusions and multinucleated
melanocytes within five of six nevi from this
family. The lesions were mainly intradermal,
composed of large epithelioid melanocytes, and
showed loss of BAP1 expression by immunohis-
tochemistry.
We report similar histopathological findings
in melanocytic lesions excised from mem-
bers of an English family in which a germline
pathogenic BAP1 mutation has been identified.
The proband was diagnosed with melanoma at
26 years of age that was clinically bland and pink
in appearance. This was initially considered to
be a melanocytic lesion of uncertain malignant
potential (MELTUMP) but on further assess-
ment, showed significant cytological atypia and
lacked maturation and was therefore treated as
a melanoma. The Breslow thickness was 2.4mm
and there was no evidence of ulceration. This
patient later developed a melanoma in situ. He
had multiple pink, bland nevi one of which
subsequently changed and this was excised
in view of his significant history. Histopatho-
logical examination showed an intradermal
melanocytic neoplasm composed of epithelioid
melanocytes with abundant cytoplasm, some of
which contained multinucleated cells (Fig. 1A)
and nuclear pseudoinclusions (Fig. 1B).
The proband’s maternal grandfather had
occupational exposure to asbestos and had
died of mesothelioma. His maternal uncle had
a history of stage IIA melanoma, which later
metastasized to a regional lymph node. Striking
pleomorphism, multinucleatedmelanocytes and
nuclear pseudoinclusions were readily identified
in this nodal metastasis.
The proband’s maternal aunt, presented
at 44 years of age with a history of a recalci-
trant scalp lesion, which had been curetted
twice elsewhere in the belief that this was a
cyst. The curettings had not been sent for
histopathological assessment. Following a fur-
ther recurrence, approximately 18 months
after onset, the lesion was partially excised by
general surgeons. Histopathology revealed a
malignant blue nevus-like melanoma showing
a highly cellular melanocytic tumor, at least
11mm in thickness; composed of spindle cells
and some dendritic-like melanocytes. Nuclear
pseudoinclusions were noted, although dis-
tributed more sparsely within this lesion. To our
knowledge, there is only one other reported case
of a 64-year-old female with a BAP1 germline
mutation who had a malignant blue nevus-like
melanoma of the scalp.2 Our patient was also
found to have a meningioma on computed
tomography (CT) scanning.
Following an invitation for screening, the
proband’s maternal cousin had a pink lesion
excised, due to a history of change. This was diag-
nosed as a spitzoid tumor of uncertainmalignant
potential (STUMP). The tumor consisted of a
lobulated, intradermal nodule composed of
pleomorphic epithelioid melanocytes, flanked
by a more diffuse melanocytic lesion with
hyperchromatic nuclei (Fig. 2A). Nuclear
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Fig. 1. A) Histopathological findings (×20) show a predominantly intradermal melanocytic lesion. Multinucleated melanocytes
can be clearly seen. B) High-power view (×63) reveals a melanocytic lesion composed of multinucleated melanocytes. Nuclear
pseudoinclusions are seen in some melanocytes. This lesion was considered to be a benign melanocytic nevus and resembled nevi
described in other patients with a BAP1 mutation.
Fig. 2. A) Low-power view (×2.5) shows an intradermal melanocytic neoplasm composed of a nodule flanked by a more diffuse
melanocytic lesion. B) High-power view (×60) demonstrates remarkable nuclear pseudoinclusions.
pseudoinclusions were numerous within the
nodular component (Fig. 2B).
Atypical spitzoid tumors are known to occur in
patients who have an inherited BAP1 mutation,
the histopathology of which is usually quite
striking in stark contrast to the bland clini-
cal appearance of these lesions.3 Recognizing
this pattern of clinical and histopathological
presentation is key to identifying possible car-
riers of a BAP1 mutation, who have a cancer
susceptibility syndrome, having a particular
diathesis to cutaneous and uveal melanomas,3
meningiomas,4 mesotheliomas5 and renal
cell cancers.1 Nuclear pseudoinclusions can
be identified in several melanocytic tumors,
including benign melanocytic nevi and even
some melanomas.1 Although non-specific, they
appear to be a prominent feature of melanocytic
lesions from patients with a germline BAP1
mutation.
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